← Open Payments lookup

OMAR AYALA: Open Payments

NPI 1952573867 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$244 in 13 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $477 · 2025 $244

Food & beverage: $244
CompanyPaymentsAmount
ABBVIE INC.4$72
Vanda Pharmaceuticals Inc.2$37
Supernus Pharmaceuticals, Inc.1$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Axsome Therapeutics, Inc.1$18
Tris Pharma Inc1$18
E.R. Squibb & Sons, L.L.C.1$17
Otsuka America Pharmaceutical, Inc.1$14

Products named: VRAYLAR, FANAPT, Qelbree, CAPLYTA, Auvelity, Onyda XR, COBENFY, REXULTI.

Industry payments across NJ — which companies pay providers there.